POPULARITY
Most people think occupational therapy is what happens after something goes wrong. Tyler Broome is here to tell you that's exactly the framing that's costing patients their independence. In this episode of the Your Health University Podcast, Jamie sits down with Tyler Broome, a Certified Occupational Therapist Assistant at Your Health, to explore what OT actually is, how it fits into a truly integrated care model, and why the therapy team often sees the earliest signs of decline — before anyone else on the care team does. Tyler brings a uniquely grounded perspective, shaped by a baseball career, a grandmother's fall, and years of working inside the homes of real patients. He articulates something most healthcare systems have yet to fully grasp: that medical outcomes and functional outcomes are deeply connected, and that a care team working in silos is a care team leaving gaps. In this episode: Why occupational therapy is defined by daily function — bathing, dressing, meal prep, medication management — not just physical recovery How OT's presence in the home gives the care team "functional health intelligence" no clinic visit can replicate The difference between saying your system is integrated and actually delivering integrated care Two real patient stories where early cross-disciplinary communication prevented a crisis from becoming a catastrophe Why the shift to value-based care makes therapy's role not just important — but essential If you work inside the Your Health system — or if you've ever wondered what the therapy team actually contributes — this conversation will change how you think about the care happening around your patients every day. www.YourHealth.Org
Around 4% of the global population has aortic stenosis, and early identification is key to reducing strain on the heart and reducing morbidity and mortality. Guest Alicia White, MSN, RN, describes signs and symptoms, diagnosis, treatment, and follow-up care following procedures.Related PCNA CE course:Aortic Stenosis: An increasing risk for structural heart disease: https://pcna.net/course/aortic-stenosis-an-increasing-risk-for-structural-heart-disease/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
Dyslexic entrepreneur and Talamo co-founder Jamie Wace joins Ben for a conversation about why so many children with dyslexia are still being missed - and how technology could radically change access to support.Jamie reflects on his own experience of school, including being told not to pursue subjects he loved because his dyslexia was misunderstood. He shares how years working in tech and entrepreneurship eventually led him to question why dyslexia assessment systems remained so inaccessible, expensive and outdated.Together, they explore the emotional impact of unidentified learning differences, why schools often rely on “wait until they fail” models, and how understanding a child's cognitive profile can shift the conversation from blame to support. Jamie also unpacks the future of assistive technology, overlapping neurodivergent conditions, and why early identification could change life trajectories for millions of children.Join us at hidden20.org/donate.________Host: Ben BransonProduction Manager: Phoebe De LeiburnéVideo Editor: James ScrivenSocial Media Manager: Charlie YoungMusic: Jackson GreenbergHead of Marketing: Kristen Fuller00:00 Introduction01:30 Jamie Wace's Dyslexia Story05:07 Being Told Not To Take History GCSE Because of Dyslexia06:00 Has Awareness of Dyslexia Actually Improved?08:31 Why Schools Need To Understand Cognitive Profiles08:48 How Talamo Was Created09:54 The Statistic That Changed Everything: 80% of Dyslexic Children Go Undiagnosed10:21 Why Traditional Dyslexia Assessments Don't Scale19:19 Dyslexia, ADHD & Understanding The Whole Child29:24 The Future of Assistive Technology For Neurodivergent Students31:16 Dyslexia, Schools & Assistive Technology In The Classroom40:32 Early Dyslexia Screening & Why Schools Are Changing44:24 Why Dyslexic People Often Make Great Communicators46:20 Dyslexia, ADHD & Neurodivergent Overlap50:51 Building Talamo For Impact, Not Profit55:46 Jamie's Green Dot BadgeThe Hidden 20% is a charity founded by AuDHD entrepreneur, Ben Branson.Our mission is simple: To change how the world sees neurodivergence.No more stigma. No more shame. No more silence.1 in 5 people are neurodivergent. That's 1.6 billion of us - yet too many are still excluded, misunderstood, or left without support.To break the cycle, we amplify voices, challenge myths, and keep showing up. Spotlighting stories, stats and hard truths. Smashing stereotypes through honest voices, creative campaigns and research that can't be ignored.Every month, over 50,000 people turn to The Hidden 20% to feel safe, seen and to learn about brilliant brains.With your support, we can reach further, grow louder, and keep fighting for the 1 in 5 who deserve more.Join us at hidden20.org/donate.Become a monthly donor.Be part of our community where great minds think differently.Brought to you by charity The Hidden 20% #1203348______________Follow & subscribe…Website: www.hidden20.orgInstagram / TikTok / Youtube / X: @Hidden20charityBen Branson @seedlip_benJamie Wace @jamiewaceIf you'd like to support The Hidden 20%, you can buy a "green dot" badge at https://www.hidden20.org/thegreendot/p/badge. All proceeds go to the charity. Hosted on Acast. See acast.com/privacy for more information.
Merlin G. Butler, MD, Medical Geneticist and Professor, Departments of Psychiatry & Behavioral Sciences and Pediatrics, University of Kansas Medical Center, Kansas City, and one of the pioneers in Prader–Willi syndrome research, discusses the clinical features of this very rare disease and the critical importance of early identification. Prader–Willi syndrome was first reported in 1956, and deletions in chromosome 15 were first identified in the 1980s. Dr. Butler has been working on the genetics of Prader–Willi syndrome since that decade. Dr. Butler said that Prader–Willi syndrome was the first example of a disorder caused by “genetic imprinting,” in which it matters whether genes are contributed by the mother or the father. In 70% of the cases of this disorder, the father's contribution is missing from chromosome 15q13, and 25% of cases are the result of both copies of chromosome 15 being from the mother (referred to as “disomy”). Babies born with this genetic anomaly have severe hypotonia, and they have no interest in sucking or feeding. They often have decreased muscle mass and energy. “These infants look like they have a major problem at birth,” stated Dr. Butler. They need to be tube-fed. Once a genetic cause is suspected, Prader-Willi syndrome is quickly diagnosed; it is a very rare disease that also has very unique features. Pediatricians may see only one of these patients every 10 years. Therefore, according to Dr. Butler, “it is the parents who oftentimes make the diagnosis, through what they have seen on the Internet, prompting genetic testing.” Despite their problems with feeding in the neonatal period, infants with Prader–Willi syndrome will begin to gain an interest in feeding by around age 2 to 3 years. By age 6 years, they develop hyperphasia. “Once their appetite is turned on,” he said, “it is never off.” Uncontrolled, this results in obesity and life-threatening conditions, such as type 2 diabetes and stomach rupture.Early identification is key, and determining the genetic subtype is extremely important to building a multidisciplinary care team. There are seven different genetic subtypes, which can impact outcomes and management. Typically, the care team will include the medical geneticist and genetic counselors, endocrinologists (to manage the use of growth hormone and diabetes-related treatment), dietitians to manage and monitor caloric intake, mental health experts to address behavioral issues and the risk of self-injury, gastroenterologists, and potentially even sleep medicine professionals. The specialists comprising the care team will change over the patient's lifespan; occupational therapy and speech therapy may well be required as the patient ages. The treatment of hyperphagia associated with Prader–Willi syndrome, the number 1 issue, is a particularly active area of research. The idea is to avoid the onset of obesity, which can lead to most of the comorbidities and complications.
Early intervention is so important! But have you ever wondered how to spot the earliest signs of communication delay and neurodivergence?We've got you covered!In this episode we talk about early signs of developmental language disorder (DLD) and Autism, ADHD, and other communication needs. These helpful tips will let you know when its time to see a speech pathologists. #SLPWe also talk about easy, free techniques you can use to support early communication whether a child has additional needs or not.
We catch up with friend of the show, Dr Carly Luke!Early identification of Australian First Nations infants at high risk of neurodevelopmental disability or neurodiverse outcomes by 12 months of age.A continuing series from Oceania Conference 2026 - live from Hobart, Tasmania, Australia!
Only 7–10% of patients who qualify for cochlear implants actually receive one. Why are so many older adults missing out on life-changing hearing care? In this episode of the BackTable ENT Podcast, guest hosts Dr. Joe Walter Kutz and Dr. Brandon Isaacson are joined by Dr. Cameron Wick of University Hospitals Cleveland Medical Center to discuss cochlear implantation in the elderly population. --- SYNPOSIS The doctors explore common barriers to cochlear implantation, persistently low referral rates, and the substantial benefits these devices can offer older adults. Dr. Wick shares insights from his recent study on patients in their 80s and 90s, highlighting meaningful improvements in speech perception and overall quality of life. The conversation also addresses surgical considerations, postoperative care, the importance of timely intervention, and updated Medicare guidelines. --- TIMESTAMPS 00:00 - Introduction 02:52 - Risks and Benefits of CI in Older Adults11:57 - Handling Anticoagulation During CI Surgery13:59 - Post-Surgery Expectations and Balance Issues16:35 - Next Day Activation and Surgical Considerations19:17 - Assessing Patient Suitability for Cochlear Implants22:45 - Setting Patient Expectations for Cochlear Implants23:39 - Barriers to Cochlear Implant Access28:07 - Importance of Early Identification and Referral31:47 - Postoperative Rehabilitation and Patient Support39:30 - Concluding Thoughts and Acknowledgements --- RESOURCES J. Walter Kutz, M.D.https://utswmed.org/doctors/joe-kutz/ Brandon Isaacson, M.D.https://utswmed.org/doctors/brandon-isaacson/ Cameron Wick, MDhttps://www.uhhospitals.org/doctors/Wick-Cameron-1063737799
Article: https://www.contemporarypediatrics.com/view/redefining-type-1-diabetes-early-identification-staging-and-clinical-implications-for-pediatric-careTable: https://thepediatriclounge.com/screening-to-prevent-dkaPetiete Trial: https://link.springer.com/article/10.1007/s00125-025-06586-1#Sec5Prevent Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2308743Screening Summit: https://medschool.cuanschutz.edu/barbara-davis-center-for-diabetes/news-profdev/conferences-events/8th-childhood-diabetes-prevention-symposium---november-10th-11th--2025In this episode, Herb Bravo is joined by Dr. Andrew Cagel, a pediatric endocrinologist, and Dr. Dan Feiten, a pediatrician , to discuss groundbreaking advancements in Type 1 Diabetes (T1D) care. The episode delves into their recent publication, 'Redefining Type 1 Diabetes: Early Identification, Staging, and Clinical Implications of Pediatric Care,' highlighting the critical importance of early detection and intervention. The guests emphasize the urgent need for universal screening.00:00 Introduction to the Pediatric Lounge00:45 Meet the Guests: Dr. Andrew Cagel and Dr. Dan Fen01:08 Redefining Type 1 Diabetes01:36 Personal Stories and Experiences01:52 The Importance of Early Detection04:40 Advancements in Type 1 Diabetes Treatment13:55 The Role of EHR and AI in Pediatric Care19:13 Future Directions and Guidelines29:06 Pivotal Study in Pediatric Diabetes30:45 The Protect Trial: Slowing Disease Progression33:19 Challenges in Screening and Implementation37:46 The Role of Pediatricians and Influencers43:03 Advocacy and Future Directions56:22 Conclusion and Final ThoughtsA Podcast taking you behind the door of the Physician's Lounge to get a deeper insight into what docs are talking about today, from the clinically profound to the wonderfully routine...and everything in between. The conversations are not intended as medical advice, and the opinions expressed are solely those of the host and guest.Support the show
Transforming T1D Care: Innovations, Early Detection, and Empowered Pediatric PracticeArticle: https://www.contemporarypediatrics.com/view/redefining-type-1-diabetes-early-identification-staging-and-clinical-implications-for-pediatric-careTherapy: https://www.contemporarypediatrics.com/view/novel-therapies-for-type-1-diabetesTable: https://thepediatriclounge.com/screening-to-prevent-dkaPetiete Trial: https://link.springer.com/article/10.1007/s00125-025-06586-1#Sec5Prevent Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa2308743Screening Summit : https://medschool.cuanschutz.edu/barbara-davis-center-for-diabetes/news-profdev/conferences-events/8th-childhood-diabetes-prevention-symposium---november-10th-11th--2025In this episode of The Pediatric Lounge, host Herb Bravo is joined by Dr. Andrew Cagel, a pediatric endocrinologist, and Dr. Dan Feiten, a pediatrician and Chief Medical Officer of Office Practicum, to discuss groundbreaking advancements in Type 1 Diabetes (T1D) care. The episode delves into their recent publication, 'Redefining Type 1 Diabetes: Early Identification, Staging, and Clinical Implications of Pediatric Care,' highlighting the critical importance of early detection and intervention. The guests emphasize the urgent need for universal screening.00:00 Introduction to the Pediatric Lounge00:45 Meet the Guests: Dr. Andrew Cagel and Dr. Dan Fen01:08 Redefining Type 1 Diabetes01:36 Personal Stories and Experiences01:52 The Importance of Early Detection04:40 Advancements in Type 1 Diabetes Treatment13:55 The Role of EHR and AI in Pediatric Care19:13 Future Directions and Guidelines29:06 Pivotal Study in Pediatric Diabetes30:45 The Protect Trial: Slowing Disease Progression33:19 Challenges in Screening and Implementation37:46 The Role of Pediatricians and Influencers43:03 Advocacy and Future Directions56:22 Conclusion and Final ThoughtsSupport the show
This podcast supports GP supervisors to recognise the potential causes of registrar difficulties, identify early signs of concern, and implement timely, appropriate strategies to address these issues.
‘Don't label her,' they said. Now she cries herself to sleep, wondering why she's too much.
Empower yourself with insights on postpartum depression (PPD) identification and treatment. Credit available for this activity expires: 07/17/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/empowering-mothers-early-identification-and-treatment-2025a1000igx?ecd=bdc_podcast_libsyn_mscpedu
About this episode: Diagnoses of autism are on the rise, but is this the result of more children being affected by the condition, or is more of a consequence of broader criteria and more screening? In this episode: a look at a new study about the number of children diagnosed with autism and what this research shows—and doesn't show. Guest: Dr. Christine Ladd-Acosta is an autism researcher and vice-director of the Wendy Klag Center for Autism and Developmental Disabilities. She is the lead Maryland investigator on a national study about the rate of autism. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Prevalence and Early Identification of Autism Spectrum Disorder Among Children Aged 4 and 8 Years - Autism and Developmental Disabilities Monitoring Network, 16 Sites, United States 2022—CDC's MMWR RFK Jr.'s autism study to amass medical records of many Americans—CBS News The NIH-Funded Autism Study Hoping to Pinpoint Gene-Environmental Interplay—Public Health On Call (March 2025) Vaccines Don't Cause Autism. Why Do Some People Think They Do?—Hopkins Bloomberg Public Health Discovering How Environment Affects Autism—Hopkins Bloomberg Public Health Magazine (2023) Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @PublicHealthPod on Bluesky @JohnsHopkinsSPH on Instagram @JohnsHopkinsSPH on Facebook @PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.
In this special episode on Early Identification and Delay of Type 1 Diabetes, Dr. Neil Skolnik this emerging area with Dr. Jay Shubrook. This special episode is supported by an independent educational grant from Sanofi. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Jay Shubrook, D.O. - Professor and Director of Diabetes Services, Touro University. Past Chair, The American Diabetes Association Primary Care Advisory Group, Past Chair of the American College of Diabetology. Selected References and Resources referred to the in the Podcast: Webinar Registration (Apr 28, 2025 10:00 AM): Early Detection Saves Lives: Implementing Type 1 Diabetes Screening in Pediatric and Primary Care References: Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes. Diabetes Care 2024;47(8):1276–1298 An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med 2019;381:603-613 Resources for Auto-antibody Testing: Type 1 Diabetes TrialNet Centers of Excellence Locations Type 1 Risk test Trialnet
In today's climate, ensuring safety in educational settings is paramount. Join us for "Prevent Harm" a crucial installment in the "Path to Safer Schools" series. This podcast brings together a panel of esteemed experts, from diverse backgrounds such as education, law enforcement, mental health, and technology. Together, they will explore innovative strategies and community engagement tactics to safeguard our students.Panel Discussion Overview:The "Prevent Harm" podcast is tailored to equip educators, administrators, parents, and policymakers with actionable insights to cultivate safer school environments. Our panel will engage in dynamic discussions covering topics such as:Early Identification of Risks: Proactive approaches to identify and mitigate potential threats, leveraging behavioral assessments and social media monitoring.Building a Culture of Safety: Strategies to foster a secure and supportive school culture where reporting concerns is encouraged.Innovative Safety Technologies: Exploration of cutting-edge technologies, from advanced security systems to anonymous reporting apps, to bolster school safety.Mental Health and Well-being: test technological advancements that can enhance school safety, from advanced security systems to apps that facilitate anonymous reporting.Mental Health and Well-being: Addressing the critical importance of mental health services in schools as a preventative measure, including counseling, peer support programs, and staff training.Community and Law Enforcement Collaboration: Effective models for collaboration between schools, local communities, and law enforcement agencies to ensure a coordinated response to safety concerns.Policy and Legislative Considerations: Discussion on current and proposed policies impacting school safety and how attendees can advocate for positive change.Speakers Kevin Eberle, EdDCOO Buffalo Public Schools, Ret.·Edingenuity, LLCDr. Kevin Eberle brings over 27 years of experience as a building administrator and former police officer to the field of education consulting, focusing on safety and culture change. As a retired school principal and COO of Buffalo Public Schools, he has also served as a teacher, counselor, and assistant principal. Dr. Eberle's multidisciplinary approach emphasizes trauma-informed care, restorative practices, and positive staff development with mindfulness techniques, demonstrating how these strategies can transform a school's culture and fabric. He is an associate with Zeal Education Group and serves on the boards of the Police Athletic League, Family Justice Center, OLV Humane Service, and Zero Now. John BullwinkelRetired US Secret ServiceJohn Bullwinkel is an accomplished Secret Service Special Agent with over 20 years of experience in national and global security leadership, focusing on personnel and facilities in the nation's capital. Transitioning to a Threat Manager role in the public sector, John brings extensive expertise in high-level security assurance and threat management. His skills encompass security system assessments, risk mitigation, high-level security operations, executive-level protection, tactical team operations, logistics, event security planning, and team leadership. Known for building valuable relationships, John excels in collaborating with stakeholders, management, team members, vendors, and clients at all organizational levels. Brian KatzSafer School SolutionsBrian Katz most recently served as the Chief Safety and Security Officer for the Broward County Public School District, the nation's 6th largest school district. With over 20 years of experience in physical security, investigations, and executive protection, he has provided security consulting for Fortune 500 companies and other unique clients.At Google, Mr. Katz was the Director of Personnel Protective Services, where he built Google's Global Security Investigations and Intelligence teams from a single person to an industry-leading strategic global organization. He developed the Executive Protection Group, Intelligence Group, and the Global Security Operations Center, managing the company's Aviation program and responding to emergent threats worldwide.Following the Marjory Stoneman Douglas High School tragedy in 2018, Broward County School District created a Division of Safety, Security, and Emergency Preparedness as a Cabinet-level Chief position. Mr. Katz was selected to fill this role in February 2019 after a national search. In this position, Mr. Katz designed the new Division from the ground up, centralizing all safety and security functions, doubling the number of security staff, and creating layers of safety and security accountability. He also developed a comprehensive safety and security training framework, rolling out these initiatives district-wide.
This week on the podcast Monique interviews the incredible Associate Professor Josephine Barbaro. Josie is a late identified Autistic ADHDer. She is a Principal Research Fellow and Psychologist at the Olga Tennison Autism Research Centre, La Trobe University, Melbourne. She is the Research Director of Identification and Diagnosis of Autism, and Clinical Director of the Victorian Early Assessment Clinic, providing neuro-affirming, transdisciplinary assessments for neurodivergence in children under 3 years. Josie's research interests are in the early identification and diagnosis of Autism, family health and well-being following a diagnosis, and Neurodiversity Affirming research and practice. In this episode Monique and Josie cover: Josie's path to understanding her own neurodivergence. The heritability of neurodivergence and the importance of taking a whole-family approach to supporting neurodivergent kids. Josie's work on early identification of Autism and the development of the SACS early identification screening tool and the ASDectect app. Josie's research and work into closing the gender gap in early diagnosis of Autism. Why early identification is so important and addressing concerns parents can have around ‘labelling'. How to share a diagnosis of Autism with your child. Debunking the myths around overdiagnosis of Autism. Things we mentioned: The Victorian Early Assessment Clinic. The SACS early identification screening tool training The ASDectect app Conversation article co-written by Josie and Marie Camin on talking to your child about their diagnosis. Conversation article co-written by Josie and Dr Nancy Sadka debunking the myth around overdiagnosis of Autism. Books to use as a conversation starter to introduce neurodivergence to a child include The Brain Forest and The Rainbow Brain, both by Sandyha Menon, and Round World Square Me by Chelsea Luker. You can contact Josie via email at veac@latrobe.edu.au or find her on her socials here. Want polished copies of our episodes in beautiful and readable pdf article format? Grab them here. Enjoyed the episode and want to support us further? Join our Patreon community! Patreon subscribers receive basic episode transcripts from Season 4 onwards, access to a monthly live zoom hang out, 50% off our episode articles, plus bonus monthly content (depending on subscription tier). Check out our Patreon page to support us, as we aim to make quality mental health care information accessible to everyone: www.patreon.com/ndwomanpod. See omnystudio.com/listener for privacy information.
Dr. Halley Alexander talks about the use of machine learning models to identify candidates for resective epilepsy surgery earlier in the disease course. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000208048
Important insights from research are illuminating secrets of Chronic Pain in Children.This episode looks at research into the complexities of chronic pain among children. Dr. Lenz discusses the growing understanding that chronic pain often arises from how the central nervous system interprets sensory inputs. The episode highlights the importance of early detection and treatment of chronic pain in altering its lifelong course. Also, it emphasizes that neuroimaging studies have found specific correlations in the brain with chronic pain, but more research is needed. 00:00 Introduction to Chronic Pain in Young People01:00 Meet Your Host, Dr. Michael Lenz01:44 The Struggles of Chronic Pain Patients02:55 The Prevalence of Chronic Pain in Children03:22 The Role of Pediatricians in Chronic Pain Management03:51 Understanding Nociplastic Pain05:10 The Importance of Early Identification and Treatment05:56 The Adolescent Brain and Cognitive Development Study09:58 The Role of Genetics in Chronic Pain12:40 The Future of Chronic Pain Treatment13:18 Understanding the Risk Factors for Chronic Pain13:46 Is there a Role of Functional MRI in Chronic Pain Diagnosis19:09 The Impact of Sex Differences on Chronic Pain20:39 Conclusion: The Future of Chronic Pain Research22:15 Final Thoughts Support the showA Fibromyalgia Starter Pack, which is a great companion to the book Conquering Your Fibromyalgia, is now available. Dr. Michael Lenz practices general pediatrics and internal medicine primary care, seeing patients from infants through adults. In addition, he also will see patients with fibromyalgia and related problems and patients interested in lifestyle medicine and clinical lipidology. To learn more, go to ConquringYourFibromyalgia.com. Remember that while Dr. Lenz is a medical doctor, he is not your doctor. All of your signs and symptoms should be discussed with your own physician. He aims to weave the best of conventional medicine with lifestyle medicine to help people with chronic health conditions live their best lives possible. Dr. Lenz hopes that the podcast, book, blog, and website serve as a trusted resource and starting point on your journey of learning to live better with fibromyalgia and related illnesses.
In this episode of the Authentic Advisor, James Mason interviews Peter Lucas from Kestrel Solutions about turning around underperforming businesses. They discuss the challenges faced by business owners and managers, the early warning signs of a troubled business, and the use of technology for early identification. Peter shares his approach to starting the turnaround process, including conducting waste audits and involving the team. He also shares a case study of a successful turnaround in the timber windows and doors industry. The episode concludes with Peter offering final tips for advisors seeking to help their clients in similar situations. Takeaways Cash flow is the number one factor to focus on in turning around a business. Advisors should have knowledge of insolvency laws and directors' duties. Implementing waste audits and involving the team can help identify areas of improvement. Constant involvement and evolution, along with constructive guidance, can prevent businesses from slipping back into bad habits. Advisors should consider requesting upfront payment and avoiding time-based billing to maintain trust and accessibility. Chapters 01:10 Introduction and Background 03:20 Challenges for Business Owners and Managers 05:45 Early Warning Signs of a Troubled Business 10:22 Using Technology for Early Identification 12:23 Starting the Turnaround Process 16:00 Waste Audits and Involving the Team 21:01 Case Study 22:43 Constant Involvement and Evolution 25:58 Final Tips for Advisors
With this concise episode, expert faculty bring you insights from the evolving area of Alzheimer disease diagnosis, including strategies for improving identification of cognitive decline and incorporating evidence-based tools in screening. Discover the impact of advanced neuroimaging and fluid markers, empowered by recent FDA approvals of anti-amyloid therapies. Come away with actionable knowledge to boost your role in cognitive health.
Jennifer Bain, MD, PhD, is an assistant professor of neurology and pediatrics at Columbia University Medical Center. Dr. Bain completed both an M.D. and PhD. as well as general pediatrics residency at Rutgers – New Jersey Medical School in New Jersey. She then trained in Child Neurology at New York Presbyterian – Columbia University Medical Center in New York City and is a board-certified neurologist with special certification in Child Neurology seeing both inpatient and outpatient pediatric neurology patients. Her clinic focuses on diagnosis and management of autism, cerebral palsy and neurodevelopmental disorders in addition to genetic disorders associated with such conditions. Her early research career focused on spinal cord and brain development after injuries such as spinal cord injury and perinatal hypoxic ischemic encephalopathy. During her residency training, her clinical research focused on studying autonomic dysfunction in children with autism spectrum disorders and neurological complications during extracorporeal membrane oxygenation. She currently works as a physician scientist at Columbia University specializing in general pediatric neurology with expertise in development, behavioral neurology, autism and cerebral palsy. Her clinical research has focused on studying the genetics of neurodevelopmental disorders including autism and cerebral palsy. The genes she has worked closely on include HNRNPH2 and related disorders, GRIN disorders, KIF1A. She is interested in understanding clinically meaningful measures in families affected by neurodevelopmental disorders and measuring longitudinal trajectories in such disorders. She has been working closely with several patient advocacy groups, researchers, and Simons Searchlight to continuously move forward in the understanding of the developing and aging brain. JOWMA Podcast | Learn The Signs, Act Early: Dr. Lisa Shulman on the Early Identification and Treatment of Autism https://anchor.fm/jowma/episodes/Learn-The-Signs--Act-Early-Dr--Lisa-Shulman-on-the-Early-Identification-and-Treatment-of-Autism-e22noo5 JOWMA Podcast | All Brains Belong with Dr. Mel Houser, MD https://anchor.fm/jowma/episodes/All-Brains-Belong-with-Dr--Mel-Houser--MD-e1t1rjn JOWMA Podcast | Uniquely Human with Dr. Barry Prizant, PhD, CCC-SLP https://anchor.fm/jowma/episodes/Uniquely-Human-with-Dr--Barry-Prizant--PhD--CCC-SLP-e1ogbg2 JOWMA Podcast | It Takes A Village- Advocating for Inclusion with Esti Schiffmiller https://anchor.fm/jowma/episodes/It-Takes-A-Village--Advocating-for-Inclusion-with-Esti-Schiffmiller-e1klr32 JOWMA Podcast | On The Spectrum: All About Autism With Dr. Devorah Segal https://anchor.fm/jowma/episodes/On-The-Spectrum-All-About-Autism-With-Dr--Devorah-Segal-e1eqv4u JOWMA Podcast | "If you've met one individual with autism, you've met one individual with autism." The Journey of Dr. Stephen Shore, Autistic Professor of Special Education https://anchor.fm/jowma/episodes/If-youve-met-one-individual-with-autism--youve-met-one-individual-with-autism--The-Journey-of-Dr--Stephen-Shore--Autistic-Professor-of-Special-Education-e1eqv4k_______________________________________________________ Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg/ Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e
https://swiy.co/WhatAreYourThoughtsIn a heartfelt conversation, host Dr. Lia Gaggino is joined by Julius Towers, a remarkable father and advocate who opens up about his personal journey raising twins with autism. From highlighting the importance of early testing to addressing equity and stigma, this episode sheds light on the realities faced by families of children with special needs. It's clear that the journey of parenting a child with autism is filled with challenges and uncertainties. Pediatricians have a crucial role to play in supporting families dealing with autism. By providing clear and compassionate communication, offering guidance and resources, and advocating for their patients, they can make a lasting impact on the lives of these children and their families. Together, we can build a world that celebrates neurodiversity. Let us remember that every child deserves access to early intervention and support, and it is up to each one of us to ensure that no child with autism is left behind. [00:33 -19:47] Early Identification is Key for Child DevelopmentEarly identification allows for timely access to necessary resources and therapies.Parents should be encouraged to observe their child's developmental milestones and seek professional guidance if any concerns arise.Early intervention services can significantly improve a child's overall development and future outcomes.Building awareness about the importance of early identification can lead to better support systems for children and their families.[19:48 - 30:02] Challenges Faced by Minoritized Populations Underdiagnosis issues in minoritized populationsReasons for missed or dismissed diagnosesImpact of underdiagnosis on health outcomesAddressing disparities in healthcare through awareness and education[30:03 - 43:26] Managing overwhelming emotionsAcknowledge the emotional whirlwind that comes with seeking servicesTry not to get caught up in thinking too far ahead into the futureEstablish some emotional boundaries to prevent feeling overwhelmedSeek out counseling or support groups to help navigate the journey[43:26 - 59:24] Steps for Early Diagnosis and Support Screen for developmental delays or disorders in children.Provide prompt referral to early intervention programs and specialized services.Educate parents and caregivers about available resources and support networks.Continuously monitor and track progress to ensure appropriate interventions.[59:25 - 1:05:48] Closing segment TakeawayYou can reach Julius TowersEmail: j.y.towers@gmail.comLinkedIn: www.linkedin.com/in/juliustowersLinks to resources mentioned on the showAutism Speaks Parent Guide: https://www.autismspeaks.org/tool-kit/parents-guide-autismCDC ADDM Network Community Report : https://www.cdc.gov/ncbddd/autism/addm-community-report/index.htmlAutistic Self Advocacy Network parent guide:
The Windward Institute and The Windward School are putting "Dyslexia in Focus" in recognition of Dyslexia Awareness Month. This month on READ, you will hear from four past READ experts on insights specific to dyslexia and topics related to screening and identification, education and intervention, and advocacy. This "Dyslexia in Focus" READ bookmark features Dr. Hugh Catts from Episode 18. In this bookmark, you will learn more about:markers of dyslexiacurrent research examining the risks of reading disabilitiesimplications for screening and interventionYou can listen to the full conversation with Dr. Catts, on Episode 18, "Early Identification and Intervention of Reading Disabilities."Stay up to date with the READ Podcast and "Dyslexia in Focus" during Dyslexia Awareness Month on YouTube, Twitter @TheWindwardInst, Instagram @thewindwardinstitute, or Facebook. Do you have questions for future topics and speakers? E-mail us at info@readpodcast.org.Until next time, READers!
In this episode of the Exceptional Girls podcast, you're invited to listen in as I talk with Dr. Linda Silverman, a well-known and respected expert in giftedness in both girls and adult women. Dr. Silverman shares invaluable information for parents and caregivers of girls who are gifted, or who they suspect may be. You'll come away with a deeper understanding of:What giftedness really is and how it presents in girls differently than boysWhat you really need to know about IQ testsWhy gifted and neurodivergent girls can easily slip through the cracksThe critical clues that your daughter may be gifted or twice exceptionalWhy early identification of neurodivergence in girls is so importantDr. Silverman also shares helpful insights about gifted adult women at the end that you won't want to miss.About the Exceptional Girls podcastIf you know and care deeply about a girl who learns, thinks, and experiences the world differently, I invite you to journey with me as we learn how we as parents, adults, and role models can help her understand, self-advocate, accept, and love herself — just as she is.To learn more, visit our website at: www.exceptionalgirlspodcast.com.
The burden of disease is high and there is a huge number of patients undiagnosed The outcomes are terrible, 1 to 5 years worse than cancers The biggest opportunity is in primary care for GPs to try and identify these patients. The easiest way is to listen to the heart and any abnormality, the patient should be referred to the heart team or cardiologist Host: Dr David Lim | Total Time: 27 mins Guests: A/Prof Kaleab Asrress, Interventional Cardiologist Register for our fortnightly FREE WEBCASTSEvery second Tuesday | 7:00pm-9:00pm AEST Click here to register for the next oneSee omnystudio.com/listener for privacy information.
evolve with dr. tay | real conversations designed for autism parents
answering YOUR questions on today's episode!Q: my child is 13 months old and has developmental delays. I'm concerned about autism. how do I know if it's autism or a developmental delay? my pediatrician says they won't start screening for autism until 18 months of age.A: Dr. Tay unpacks the American Academy of Pediatrics guidelines for autism screening and breaks down the science to address this question. in short, autism can be diagnosed accurately (for some but not all children) beginning at 14 months of age. practical next steps are provided, with encouragement to act early so your child can get necessary supports as soon as possible.RESOURCES⚡️ the research study referenced in today's episode: https://pubmed.ncbi.nlm.nih.gov/31034004/ ⚡️ join the Evolve Facebook community to participate in the episode Q+As >> facebook.com/groups/evolveautism⚡️ learn from me and submit your questions [could be featured on a future episode] >>Instagram @the.dr.tayTikTok @the.dr.tayLinkedIn @the-dr-tay⚡️ want to learn more about Dr. Tay's Whole Family Approachᵀᴹ and current services offered? schedule a free consult call here or email admin@drtaylorday.com if you have questions.DISCLAIMER >> anything shared on this podcast should not be considered clinical advice, and you should consult with your team of medical, mental health, and developmental providers if you need support.
This episode from the 2022 Midyear Clinical Meeting discusses the current methodologies used in identifying COVID-19 and how pharmacists can evaluate commercial genetic tests used in identifying respiratory pathogens and antibiotic-resistant markers. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Dr. Lisa Heidi Shulman M.D. is a Professor Pediatrics at the Albert Einstein College of Medicine at the Children's Hospital at Montefiore. A Developmental Pediatrician with over 30 years at the institution, Dr. Shulman is the Director of Autism Services, and interim Director of the Rose F. Kennedy Children's Evaluation & Rehabilitation Center at Montefiore. She also directs the Leadership Education in Neurodevelopmental and related Disabilities grant through Maternal and Child Health Bureau.Dr. Shulman currently serves on the Autism Sub-committee of the National AAP Council on Children with Disabilities, serving on the Education, Learn the Signs Act Early, and Payer Advocacy Committees. From 2016-2019 she served as the Centers for Disease Control Act Early Ambassador to New York State.A graduate of Brown University and University of Pennsylvania School of Medicine. She is board-certified in Pediatrics and Developmental and Behavioral Pediatrics. Her clinical and research interests include: early identification of autism, overcoming healthcare disparities in autism diagnosis, and follow up of children with an early diagnosis of Autism. _______________________________________________________ Related Episodes: On the Spectrum: All About Autism with Dr. Devorah Segal | JOWMA Podcast https://podcasters.spotify.com/pod/show/jowma/episodes/On-The-Spectrum-All-About-Autism-With-Dr--Devorah-Segal-e1eqv4u Uniquely Human with Dr. Barry Prizant, PhD, CCC-SLP | JOWMA Podcast https://open.spotify.com/episode/2micH8mmCnbAffltumUVUS?si=bf8695c683444b56 "If you've met one individual with autism, you've met one individual with autism." The Journey of Dr. Stephen Shore, Autistic Professor of Special Education | JOWMA Podcast https://spotifyanchor-web.app.link/e/w6iz8ynG9yb Ask The Expert: ADHD and Autism, Q &A with Developmental-Behavioral Pediatrician Dr. Amir Miodovnik | JOWMA Podcast https://spotifyanchor-web.app.link/e/CTzR1UxG9yb _______________________________________________________ Become a JOWMA Member! www.jowma.org Follow us on Instagram! www.instagram.com/JOWMA_org Follow us on Twitter! www.twitter.com/JOWMA_med Follow us on Facebook! https://www.facebook.com/JOWMAorg/ Stay up-to-date with JOWMA news! Sign up for the JOWMA newsletter! https://jowma.us6.list-manage.com/subscribe?u=9b4e9beb287874f9dc7f80289&id=ea3ef44644&mc_cid=dfb442d2a7&mc_eid=e9eee6e41e
As part of our ongoing dialogue around clinical care pathways and the complex of metabolic diseases, SurfingNASH dedicates a session to focus on the key relationship and interplay between endocrinology and hepatology. This topic rings familiar in the Rising Tide series, our podcast for frontline education, where Ken Cusi often notes the need for endocrinologists to become comfortable diagnosing Fatty Liver disease (and prescribing pioglitazone) and for hepatologists to become more comfortable prescribing GLP-1s. To expand on these critical ideas with the SurfingNASH community, Jörn Schattenberg, Louise Campbell and Roger Green are joined by Cyrielle Caussy, Professor of Nutrition and Endocrinologist-Diabetologist at Lyon 1 University and Lyon South Hospital, Hospices Civils de Lyon (France). Cyrielle is an expert in the clinical care of metabolic disease, including type 2 diabetes, obesity and NAFLD, and she is leading a clinical and research program focused on metabolic liver disease at the Lyon Hepatology Institute. 02:14 Introducing Cyrielle Caussy and Her Professional BackgroundNew to the podcast, Cyrielle takes a moment to outline her career trajectory and how she became interested in Fatty Liver disease and its growing area of overlap within the wider scope of medical care.08:42 Educating Endocrinologists on the Power of NITs Developed in HepatologyFrom here, Roger describes overarching questions that the episode aims to cover:What does the interaction between endocrinologists and hepatologists look like from their relative perspectives? In practical terms, how does each approach care pathways, referrals and collaboration? What about either speciality would be key for the other to learn more about, develop and integrate? Jörn comments on the value of deploying the NITs developed by the hepatology community to endocrinology clinics. He notes the practical barriers which could hinder uptake and utilization. Among other insights, Cyrielle underscores the importance behind raising awareness among our endocrinology colleagues that patients in routine screening are regularly diagnosed with advanced fibrosis and cirrhosis in the absence of symptoms.14:32 The Importance of Early Identification in At-Risk Populations and Implementing GuidelinesRoger notes that around 50% of all cirrhosis is diagnosed for the first time during a decompensation event at the emergency department. He asks whether the endocrinology clinic is the right place to identify patients much sooner. Jörn suggests the answer is yes considering that we know the risk and prevalence of advanced fibrosis in this population to be high. The group goes on to discuss requesting and receiving lab results in their respective different systems.25:55 Discussing the Patient Perspective in Endocrinology ClinicsLouise asks how do patients respond when informed of fibrosis or other liver related conditions in the endocrinology clinic setting. 33:40 Biomarkers, Holistic Metabolic Assessment and PathwaysThe groups discusses takeaways from various studies on the interrelatedness of concurrent metabolic conditions and the influence of liver health.40:57 Calling All Parties to Invest in Fighting Fatty LiverIf you enjoy the episode, have questions or interest around endocrinology and Fatty Liver disease, we kindly ask that you submit reviews wherever you download the discourse. Alternatively, you can write to us directly at questions@SurfingNASH.com.Stay Safe and Surf On!
In this episode of CUBIST, Amanda and Don discuss the article, "Risk Factors for high symptom burden three months after traumatic brain injury and implications for clinical trial design: A TRACK-TBI study” by Nancy Temkin and colleagues, published in the Journal of Neurotrauma in June of 2022. Article Citation: Temkin, N., Machamer, J., Dikmen, S., Nelson, L. D., Barber, J., Hwang, P. H., Boase, K., Stein, M. B., Sun, X., Giacino, J., McCrea, M. A., Taylor, S. R., Jain, S., Manley, G., & TRACK-TBI Investigators (2022). Risk Factors for High Symptom Burden Three Months after Traumatic Brain Injury and Implications for Clinical Trial Design: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. Journal of Neurotrauma, 39(21-22), 1524–1532. Article LINK: https://pubmed.ncbi.nlm.nih.gov/35754333/ CUBIST is a podcast for healthcare providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury (TBI) most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views, opinions, and/or findings in this podcast are those of the host and subject matter experts. They should not be construed as an official Department of Defense position, policy, or decision unless designated by other official documentation. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.
In this episode of CUBIST, Amanda and Don discuss the article, "Risk Factors for high symptom burden three months after traumatic brain Injury and implications for clinical trial design: A TRACK-TBI study” by Nancy Temkin and colleagues published in the Journal of Neurotrauma in June of 2022. Article Citation: Temkin, N., Machamer, J., Dikmen, S., Nelson, L. D., Barber, J., Hwang, P. H., Boase, K., Stein, M. B., Sun, X., Giacino, J., McCrea, M. A., Taylor, S. R., Jain, S., Manley, G., & TRACK-TBI Investigators (2022). Risk Factors for High Symptom Burden Three Months after Traumatic Brain Injury and Implications for Clinical Trial Design: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study. Journal of Neurotrauma, 39(21-22), 1524–1532. Article LINK: https://pubmed.ncbi.nlm.nih.gov/35754333/ CUBIST is a podcast for healthcare providers produced by the Traumatic Brain Injury Center of Excellence. We discuss the latest research on traumatic brain injury (TBI) most relevant to patient care. For more about TBI, including clinical tools, go to www.health.mil/TBICoE or email us at dha.TBICoEinfo@health.mil. The views, opinions, and/or findings in this podcast are those of the host and subject matter experts. They should not be construed as an official Department of Defense position, policy, or decision unless designated by other official documentation. Our theme song is “Upbeat-Corporate' by WhiteCat, available and was used according to the Creative Commons Attribution-Noncommercial 4.0 license.
In this episode, Dr. Vincent Alfonso, psychologist and Professor in the School of Education at Gonzaga University, discusses why early, accurate identification is so important, what developmentally-based evaluations typically entail, how early a child can be identified with an LD, and why universal screeners for learning disabilities are so essential.
Sonam Kiwalkar, MD, Vancouver Clinic CME Credit Available for all Providence Providers In order to claim CME credit, please click on the following link: https://forms.office.com/r/FwhWwm6F4W (or copy & paste into your browser) Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Planning Committee & Faculty Disclosure: The Planning Committee and faculty have no relevant financial relationships with ineligible companies interests to disclose. Original Date: September 20, 2022 End Date: September 20, 2023
Sonam Kiwalkar, MD, Vancouver Clinic CME Credit Available for all Providence Providers In order to claim CME credit, please click on the following link: https://forms.office.com/r/FwhWwm6F4W (or copy & paste into your browser) Accreditation Statement: Providence Oregon Region designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 creditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Providence Oregon Region is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Planning Committee & Faculty Disclosure: The Planning Committee and faculty have no relevant financial relationships with ineligible companies interests to disclose. Original Date: September 20, 2022 End Date: September 20, 2023
To get an edge in your prep career, you need to learn about the 2/10ths speed and agility and the man behind it, DeWayne Brown. In this interview, I deep dive into what makes his training approach so innovative and what's the secret to his track record for success. If you want to understand the nuances of the early identification process, specialized training and the competitive environment are needed.This episode is for you."You get what you Earn."Just a few Pros that have gone through his program. Aaron Donald, Los Angeles Rams Jaquan Brisker, Chicago Bears Miles Sanders, Philadelphia EaglesSky Moore, Kansas City Chiefs Does your son dream of playing college football at the highest level?www.ligbluechip.comConnect with Justin and the Blue Chip Academy on Social Media:https://linktr.ee/JKingLIG
CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
Please visit answersincme.com/TAC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in infectious diseases discusses the early identification and treatment of patients with COVID-19 who are at a higher risk of progression to severe illness. Upon completion of this activity, participants should be better able to: Identify nonhospitalized patients with COVID-19 who have risk factors for progression to severe illness; Describe national guideline recommendations for the therapeutic management of nonhospitalized patients with COVID-19 who are at risk for progression to severe illness; and Outline a personalized management approach to enhance outcomes for nonhospitalized patients who are diagnosed with COVID-19 and are at risk for progression to severe illness.
Please visit answersincme.com/TAC860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in infectious diseases discusses the early identification and treatment of patients with COVID-19 who are at a higher risk of progression to severe illness. Upon completion of this activity, participants should be better able to: Identify nonhospitalized patients with COVID-19 who have risk factors for progression to severe illness; Describe national guideline recommendations for the therapeutic management of nonhospitalized patients with COVID-19 who are at risk for progression to severe illness; and Outline a personalized management approach to enhance outcomes for nonhospitalized patients who are diagnosed with COVID-19 and are at risk for progression to severe illness.
Central nervous system (CNS) tumors account for a quarter of all cancers in children aged 1 to 19 years. Nearly 70% of CNS tumors can be effectively treated, but early detection is critical to allow for the best possible treatments and outcomes. Too often, CNS tumors are initially misdiagnosed as more common pediatric conditions such as migraine, gastroenteritis or other psychologic and behavioral problems. In this episode, we discuss the classic signs and presentations of CNS tumors to support early detection. Our guest for today's episode is Dr. Green. Dr. Green is part of the Center for Cancer and Blood Disorders Team at Children's Hospital Colorado and is Assistant Professor of Pediatrics, Hematology/Oncology/and Bone Marrow Transplantation at the University of Colorado School of Medicine.
Sepsis impacts over 1.7 million Americans each year resulting in over 270,000 deaths (a death every 2 minutes). According to a Centers for Disease Control and Prevention (CDC) study, as many as 87% of sepsis cases begin outside of the hospital, so early identification and treatment in the post-acute setting is key to reducing morbidity and mortality in this population. Healthcare personnel in skilled nursing facilities play a significant role in early identification and treatment of sepsis. This presentation will overview sepsis, its pathophysiology, signs and symptoms and treatment within the context of skilled nursing and long term care (LTC). It will outline an early identification and treatment process for sepsis and how to incorporate it into usual work processes including communication strategies to providers that focus on action. Strategies for patient and family education will also be reviewed. To watch the lecture, and learn more about the speaker, please visit https://www.continulus.com
Welcome to a new Hot Topics Podcast from NB Medical with Dr Neal Tucker. It's the summer holidays! We hope a little pressure is off at your practices and you might even get a break yourself. In this podcast, we discuss the latest news including whether GPs simply aren't working hard enough and debate a £10 charge for DNAs.In research, we look at new data from JAMA suggesting patients are at increased risk of MI shortly after a flare of gout, a fantastic paper in the BJGP presenting data showing how it may be possible to improve early identification of colorectal cancer based on common symptoms and blood results, and more from the BJGP with qualitative research exploring the barriers to shared decision making in patients with multimorbidity. ReferencesJAMA Gout and acute CVDBJGP Early Identification of CRCBJGP Shared decision making and multimorbidity
In this podcast, Jill Zwicker discusses her papers 'Early intervention for children with/at risk of developmental coordination disorder: a scoping review' and 'Early identification of children with/at risk of developmental coordination disorder: a scoping review'. The papers are available to read here: https://onlinelibrary.wiley.com/doi/full/10.1111/dmcn.14803 https://onlinelibrary.wiley.com/doi/10.1111/dmcn.14804 Subscribe to our channel for more: https://bit.ly/2ONCYiC ___ Listen to all our episodes: https://bit.ly/2yPFgTC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN) has defined the field of paediatric neurology and childhood-onset neurodisability for over 60 years. DMCN disseminates the latest clinical research results globally to enhance the care and improve the lives of disabled children and their families. DMCN Journal - https://onlinelibrary.wiley.com/journal/14698749 ___ Watch DMCN videos on our YouTube channel: https://bit.ly/2ONCYiC Find us on Twitter! @mackeithpress - https://twitter.com/mackeithpress
CME credits: 0.50 Valid until: 19-05-2023 Claim your CME credit at https://reachmd.com/programs/cme/qad-addressing-challenges-in-alzheimers-disease-from-early-identification-to-new-treatment-considerations/13485/ Alzheimer's Disease (AD) is a progressive disease that presents challenges when it comes to the early diagnosis and treatment of patients. That's why this two-part series will help answer your specific questions while providing expert insights into these challenges. In this first activity, a panel of esteemed faculty will examine the case of a patient who was diagnosed early with mild cognitive impairment (MCI) due to AD, prior to dementia. Using this patient case, faculty will delve into both the importance of early identification of AD and how to detect it early. The panel will then discuss the pathobiology of AD and potential treatments in development to target this pathology. Finally, the panel will explore current treatment options, including the appropriate use of anti-amyloid monoclonal antibody (mAb) treatment. If you would like to view the second part of this series, please click here.
CME credits: 0.50 Valid until: 19-05-2023 Claim your CME credit at https://reachmd.com/programs/cme/qad-addressing-challenges-in-alzheimers-disease-from-early-identification-to-new-treatment-considerations/13485/ Alzheimer's Disease (AD) is a progressive disease that presents challenges when it comes to the early diagnosis and treatment of patients. That's why this two-part series will help answer your specific questions while providing expert insights into these challenges. In this first activity, a panel of esteemed faculty will examine the case of a patient who was diagnosed early with mild cognitive impairment (MCI) due to AD, prior to dementia. Using this patient case, faculty will delve into both the importance of early identification of AD and how to detect it early. The panel will then discuss the pathobiology of AD and potential treatments in development to target this pathology. Finally, the panel will explore current treatment options, including the appropriate use of anti-amyloid monoclonal antibody (mAb) treatment. Throughout this activity, we will gather questions from clinicians like you who care for patients living with dementia, and then in part two of this series, we will answer some of the questions generated from this first activity.
Elevated intracranial pressure is a life-threatening cancer complication, but oncology nurses can take steps to prevent and recognize it in their patients. ONS member Mary Elizabeth Davis, DNP, RN, AOCNS®, clinical nurse specialist at Memorial Sloan Kettering Cancer Center in New York, NY, and member of the New York City ONS Chapter, talks with Stephanie Jardine, BSN, RN, oncology clinical specialist at ONS, about the latest nursing strategies for increased intracranial pressure, a situation that can occur with a brain tumor, abscess, infection, or other conditions that increases or obstructs cerebrospinal fluid or blood flow in the brain. This episode is part of a series about oncologic emergencies; the previous episodes are linked in the episode notes. You can also earn free NCPD contact hours by completing the evaluation linked in the episode notes. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0 Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at myoutcomes.ons.org by April 15, 2024. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation. Episode Notes Check out these resources from today's episode: Complete this evaluation for free NCPD. Previous Oncology Nursing Podcastepisodes on oncologic emergencies Oncology Nursing Forum article: Early Identification of Intracranial Hemorrhage Using a Predictive Nomogram ONS book: Understanding and Managing Oncologic Emergencies: A Resource for Nurses(third edition) ONS course: Essentials in Oncologic Emergencies for the Advanced Practice Provider ONS course: Oncologic Emergencies ONS course: Treatment and Symptom Management—Oncology RN ONS Huddle Cards™ American Association of Neuroscience Nurses American Brain Tumor Association To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.
Age-related hearing loss is a common problem in adults, and it might be starting earlier than we think. Courtney Coburn Glavin, a PhD candidate, at Northwestern University sits down with Dr. Brian Taylor to review her research using DPOAEs to identify hearing loss of early onset in young adults and the clinical implications of her work. They also discuss the limitations of the pure tone audiogram and intervention strategies for people with subclinical forms of hearing loss. Be sure to subscribe to our YouTube channel for the latest episodes each week, and follow This Week in Hearing on LinkedIn and Twitter: https://www.linkedin.com/company/this-week-in-hearing/ https://twitter.com/WeekinHearing
Central nervous system (CNS) tumors account for a quarter of all cancers in children aged 1 to 19 years. Nearly 70% of CNS tumors can be effectively treated, but early detection is critical to allow for the best possible treatments and outcomes. Too often, CNS tumors are initially misdiagnosed as more common pediatric conditions such as migraine, gastroenteritis or other psychologic and behavioral problems. In this episode, we discuss the classic signs and presentations of CNS tumors to support early detection. Our guest for today's episode is Dr. Green. Dr. Green is part of the Center for Cancer and Blood Disorders Team at Children's Hospital Colorado and is Assistant Professor of Pediatrics, Hematology/Oncology/and Bone Marrow Transplantation at the University of Colorado School of Medicine. Do you have thoughts about today's episode or suggestions for a future topic? Write to us, Chartingpediatrics@childrenscolorado.org
Clinical utilisation of the Infant Monitor of vocal Production (IMP) for early identification of communication impairment in young infants at-risk of cerebral palsy: a prospective cohort studyR Ward, N Hennessey, E Barty, C Elliott, J Valentine & R Cantle MooreABSTRACTAim: To report prospective longitudinal data of early vocalisations of infants identified “at-risk” of cerebral palsy (CP) for early identification of communication impairment.Method: This case-control longitudinal prospective cohort study reports on the assessment of 36 infants, 18 identified as at-risk of CP at the time of enrolment and 18 typically developing (TD) children, at three time points: 6 months, 9 months and 12 months of age, Data were obtained through criterion and norm referenced assessments of vocalisation behaviours.Results: Early vocal behaviours of infants identified as at-risk of CP did not differ from their age matched peers at 6 months of age, however, significant group differences emerged at 9 and 12 months when pre-canonical and canonical babble typically emerge. Generalised linear mixed models analysis showed that the rate of development of early language ability and more complex speech-related vocal behaviours was slower for infants at risk of CP when compared to TD infants, with over 75% of infants with CP showing below normal vocal production and impaired language by 12 months of age.Interpretation: Our data suggest characteristics of infant vocalisations associated with pre-canonical and canonical babbling provide a strong evidence base for predicting communication outcomes in infants at risk of CP.https://doi.org/10.1080/17518423.2021.1942280
Sow lameness continues to trouble hog operations in the US, causing high numbers of involuntary removals from herds. The post Early identification critical in preventing sow lameness appeared first on Pig Health Today.
Sow lameness continues to trouble hog operations in the US, causing high numbers of involuntary removals from herds. These expensive sow removals can be reduced by identifying lameness issues early and addressing equipment hazards that lead to sow injuries, reported Michael Pierdon, VMD, Four Star Veterinary Service, Elizabethtown, Pennsylvania.